AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights.
The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Country | United States |
IPO Date | Jun 16, 2000 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 13,676 |
CEO | Dr. Gary S. Guthart Ph.D. |
Contact Details
Address: 1020 Kifer Road Sunnyvale, California United States | |
Website | https://www.intuitive.com |
Stock Details
Ticker Symbol | ISRG |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001035267 |
CUSIP Number | 46120E602 |
ISIN Number | US46120E6023 |
Employer ID | 77-0416458 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Dr. Gary S. Guthart Ph.D. | Chief Executive Officer & Director |
Jamie E. Samath | Senior Vice President & Chief Financial Officer |
Brian King | Vice President, Treasurer & Head of Investor Relations |
David J. Rosa | President & Director |
Dr. Christopher R. Carlson Ph.D. | Executive Vice President of Research, Corporate Development & Intuitive Ventures |
Fredrik Widman | Vice President, Principal Accounting Officer & Corporate Controller |
Gary H. Loeb J.D. | Senior Vice President, General Counsel & Chief Compliance Officer |
Henry L. Charlton | Senior Vice President & Chief Commercial and Marketing Officer |
Patricia Wadors | Chief Human Resources Officer |
Robert DeSantis | Executive Vice President and Chief Strategy & Corporate Operations Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 06, 2025 | 8-K | Current Report |
Dec 11, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Nov 26, 2024 | 4 | Filing |
Nov 26, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |
Nov 13, 2024 | 4 | Filing |
Nov 12, 2024 | 4 | Filing |
Nov 12, 2024 | 4 | Filing |